Can Neozep (bromazepam) or Bioflu (fluoxetine) cause erythema multiforme?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Neozep or Bioflu Cause Erythema Multiforme?

Critical Clarification Required

The medications you're asking about—Neozep and Bioflu—are NOT bromazepam or fluoxetine. These are brand names for over-the-counter cold/flu combination products commonly available in the Philippines and other Asian markets, typically containing paracetamol (acetaminophen), phenylephrine, chlorpheniramine, and sometimes other ingredients like caffeine or dextromethorphan 1, 2.

Direct Answer Based on Individual Components

Yes, both Neozep and Bioflu can potentially cause erythema multiforme, though the risk is relatively low, primarily through their shared ingredient paracetamol (acetaminophen) and potentially through chlorpheniramine. 2

Component-Specific Risk Assessment

Paracetamol/Acetaminophen Risk

  • Acetaminophen is a documented cause of erythema multiforme, appearing in multiple case series as an implicated drug in drug-induced erythema multiforme 2, 3.
  • The mechanism involves a type IV hypersensitivity reaction, with drugs constituting one of the most common causes of erythema multiforme after infections 1, 2.

Antihistamine (Chlorpheniramine) Considerations

  • While first-generation antihistamines like chlorpheniramine are less commonly reported as triggers, any medication can theoretically precipitate erythema multiforme through immune-mediated mechanisms 2.
  • Antihistamines are actually used to treat erythema multiforme symptomatically, suggesting lower inherent risk 1, 4.

Phenylephrine and Other Decongestants

  • Sympathomimetic decongestants like phenylephrine have minimal documented association with erythema multiforme in the available literature 1, 2.

Clinical Recognition Features

If erythema multiforme develops, you will see:

  • Fixed targetoid lesions lasting minimum 7 days (not transient like urticaria which resolves within 24 hours) 5, 1.
  • Symmetrical distribution predominantly on extremities, especially extensor surfaces, spreading centripetally 1.
  • Possible mucosal involvement in more severe cases 1, 4.

Critical Management Algorithm

If erythema multiforme is suspected:

  1. Immediately discontinue both Neozep and Bioflu - all potentially causative medications must be stopped 2, 4.

  2. Assess severity:

    • Isolated cutaneous involvement: outpatient management with topical corticosteroids and oral antihistamines 1, 4.
    • Mucosal involvement: may require hospitalization for IV fluids and electrolyte management 1, 4.
  3. Rule out Stevens-Johnson Syndrome - if you see widespread erythematous or purpuric macules with blisters rather than discrete targetoid lesions, this is a medical emergency requiring immediate hospitalization 1.

  4. Investigate alternative triggers - herpes simplex virus and Mycoplasma pneumoniae are more common causes than drugs, so consider recent infections 1, 2.

Important Caveats

  • The actual risk is low - while paracetamol can cause erythema multiforme, it remains a rare adverse effect given the billions of doses consumed worldwide 2.
  • Never rechallenge - if erythema multiforme develops after taking these products, permanent avoidance of all components is mandatory 2, 4.
  • Document the specific brand and formulation - different markets may have varying formulations of "Neozep" and "Bioflu," so knowing exact ingredients is crucial for future avoidance 2.

References

Research

Erythema Multiforme: Recognition and Management.

American family physician, 2019

Research

Current Perspectives on Erythema Multiforme.

Clinical reviews in allergy & immunology, 2018

Research

Vesicular Contact Reaction May Progress into Erythema Multiforme.

Acta dermatovenerologica Croatica : ADC, 2016

Research

Recent Updates in the Treatment of Erythema Multiforme.

Medicina (Kaunas, Lithuania), 2021

Guideline

Acute Urticaria and Erythema Multiforme Therapeutics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.